Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Subjects: | |
| Online Access: | Enlace web Path |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
- Impact of confinement measures due to the COVID-19 pandemic on people living with dementia and their caregivers in Spain
- Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
- Increased alcohol use to cope with COVID-19-related anxiety one year into the coronavirus pandemic
- Coping behaviors associated with decreased anxiety and depressive symptoms during the COVID-19 pandemic and lockdown
- Anxiety and depressive symptoms in children and adolescents during COVID-19 pandemic: A transcultural approach
- Prevalence of depression, anxiety, burden, burnout, and stress in informal caregivers: An umbrella review of meta-analyses